Header Logo

Connection

JASON SOBIESKI to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications JASON SOBIESKI has written about Protein Kinase Inhibitors.
JASON SOBIESKI
Connection Strength
0.121
Protein Kinase Inhibitors
  1. Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors. Int J Mol Sci. 2019 May 22; 20(10).
    View in: PubMed
    Score: 0.121
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.